GLOBAL DISCOVERY & DEVELOPMENT INNOVATION FORUM

Leverage Innovation To Transform Drug Discovery & Development Productivity.

Network with up to 150 leaders, create a competitive advantage and revolutionise your R&D Innovation at the 3rd Annual Global Discovery to Development Innovation Forum 2010.
The Annual GDDIF is the leading R&D summit for industry leaders and strategists. It is the only two day gathering dedicated to both strategy and Innovation across the drug discovery & development realm.

	Read More


	PREVIOUS
	GBX SUMMITS SPEAKERS
		view all


	Steve Street Vice President for Research. Head of Pfizer R&D Cont. Improvement


	Gross, Gerhard, Section Director ADME in AstraZeneca UK


	Dr Harsukh Parmar Global Head of Early Clinical Dev't, Resp. & Inflammation Therapy Astra Zenica


	Tony Wood Vice President, Head of Worldwide Medicinal Chemistry, Pfizer Global Research & Development

R&D Innovation & Strategies –Integrated Strategies To Over Come Pitfalls, Enhance Drug Discovery, Overcome Attrition & New Prediction Tools That Drive Clear Decision Making.

Focused Sirna Screens In Disease Based Assays - The Fast Track To A Target

Non-Invasive, Label-Free Assays - Getting the Most Out of your Targets and a Handle on Off-Target Effects

In Silico Innovation To Solve Drug Discovery – In-Silico Data, Data Mining, Predictive Modeling,

Exploring the impact & success rate of HTS Compound Library Screening.

Partnerships, Alliances & Outsourcing –Successful Partnerships, Managing Alliances, Balancing Conflicting Interests, Biotech Technology Platforms

Intergration of technologies & applications to bridge the gap between discovery, validation & development

How do you create intelligence from all this data, both structured and unstructured, across the entire value chain?

Streamline data processes and integration whilst improving early decision making and lowering attrition through the benefit of developing a dynamic workflows and an efficient infrastructure.

“An innovative approach”-lean/ 6-sigma efforts and organisational structures supporting lead optimisation."

Alternative cost effective screening methods and techniques to strengthen assay effectively. Bringing in-vitro screening for HTS, hit optimisation & lead optimisation together.

DISCLAIMER

While great efforts were made to ensure accurate and up-to-date information on this website, Gbx Summits makes no representations or warranties whatsoever, express or implied, as to the content of this website and the products and services described therein, including, without limitation, with respect to accuracy, completeness, non- infringement, merchantability, fitness for a particular purpose, or availability, and Gbx Summits disclaims any liability for losses or damages of any kind, including losses or damages resulting from the transmission or downloading of computer viruses.

The content of this website may be changed at any time without notice. Links to other websites are provided for the user's convenience. Gbx Summits does not express an opinion on the content or the properties of such linked websites and disclaims any liability in connection therewith. The information contained on this website does not constitute an offer for products or services. Investors must not rely on information provided on this website for investment decisions.

Any enquiries please email: legalteam@gbxsummits.com

Bench-mark and network with up to 120 decision makers & business strategists.

Choose from up to forty presentations from some of the world's most renowned speakers.

Engage in private meetings with leading suppliers or delegates through our business exchange.

Join executive panels & workshops to debate and discuss both strategy and innovation.

Create a proposal with your customers in two-way dialogue prior the summit.